Tumor escape from immune recognition: Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1633-1641

  Maeurer, Markus J ^a,d   Gollin, Susanne M ^b   Martin, Dina ^a   Swaney, William ^b   Bryant, John ^b   Castelli, Chiara ^c   Robbins, Paul ^a   Parmiani, G ^c   Storkus, Walter J ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

antigen processing; human melanoma; T cell recognition; TAP; tumor antigens

Indexed keywords

MELANOMA ANTIGEN; TUMOR ANTIGEN;

ADULT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; RECURRENT CANCER; T LYMPHOCYTE; TUMOR IMMUNOLOGY;

EID: 10144223555     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118958     Document Type: Article

References (47)

1. Rosenberg, S.A., B. Packard, P.M. Aebersold, D. Solomon, S.L. Topalian, A. Toy, P. Simon, M.T. Lotze, J.C. Yang, C.A. Seipp, et al. 1988. Immunotherapy of patients with metastatic melanoma using tumor infiltrating lymphocytes and interleukin-2. N. Engl. J. Med. 319:1676-1680.
2. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
3. Coulie, P.G., V. Brichard, A. VanPel. T. Wölfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.-P. Szikora et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
4. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P.F. Robbins. L. Rivoltini, J.R. Yanelli, E. Apella, and S.A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-352.
5. Castelli, C., W.J. Storkus, M.J. Maeurer, D.M. Martin, E.C. Huang, B.N. Pramanik, T.L. Nagabhushan, G. Parmiani, and M.T. Lotze. 1995. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J. Exp. Med. 181:363-368.
6. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakkaguchi, E. Appella, J.R. Yanelli, G.J. Adema, T. Kimi, and S.A. Rosenberg. 1994. Identification of melanoma antigens recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natll. Acad. Sci. USA. 91:6458-6462.
7. Bakker, A.B., M.W. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
8. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Wash. DC). 264:716-719.
9. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
10. Robbins, P.F., M. El-Gamil, Y. Kawakami, and S.A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124-3126.
11. Lotze, M.T., J.A. Carrasquillo, J.N. Weinstein, G.J. Bryant, P. Perentesis, J.C. Reynolds, L.A. Matis, R.R. Eger, A.M. Keenan, I. Hellstrom, et al. 1986. Monoclonal antibody imaging of human melanoma: radio-immunodetection by subcutaneous or systemic injection. Ann. Surg. 204:223-235.
12. Elder, E.M., and T.L. Whiteside. 1992. Processing of tumors for vaccine and/or tumor infiltrating lymphocytes. N.R. Rose, E. Conway de Macaio, J.L. Fahey, H. Friedman, and G.M. Penn, editors. In: Manual of Clinical Laboratory Immunology. 4th ed. American Society for Microbiology, Washington, D.C. 817-819.
13. Maeurer, M.J., S. Hurd, D.M. Martin, W.J. Storkus, and M.T. Lotze. 1995. Cytolytic T-cell clones defined HLA-A2 restricted human cutaneous melanoma peptide epitopes - correlation with T-cell receptor usage. Cancer J. Sci. Am. 1:162-170.
14. ISCN. 1991. Guidelines for Cancer Cytogenetics, Supplement to the International System for Cytogenetic Nomenclature. F. Mitelman, editor. Karger, Basel, Switzerland.
15. Storkus, W.J., H.J. Zeh, III, R.D. Salter, and M.T. Lotze. 1993. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells. J. Immunother. 14:94-103.
16. Storkus, W.J., H.J. Zeh, III. M.J. Maeurer, R.D. Salter, and M.T. Lotze. 1993. Identification of human melanoma peptides recognized by class I-restricted tumor infiltrating lymphocytes. J. Immunol. 151:3719-3727.
17. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
18. Restifo, N.P., F. Esquivel, Y. Kawakami, J.M. Yewdell, J.J. Mule, S.A. Rosenberg, and J.R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265-272.
19. Cromme, F.V., J. Airey, M.-T. Heemels, H.L. Ploegh, P.J. Keating. P.L. Stern, C.J.L.M. Meijer, and J.M.M. Walboomers. 1994. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179:335-340.
20. Spies, T., and R. DeMars. 1991. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature (Lond.). 351:323-324.
21. Danos, O., and R. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA. 85:6460-6464.
22. Anichini, A., C. Maccalli, R. Mortarini, S. Salvi, A. Mazzocchi, P. Squarcina, M. Herlyn, and G. Parmiani. 1993. Melanoma cells and nomal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177:989-998.
23. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
24. Van der Bruggen, P., J.-P. Szikora, P. Boel, C. Wildmann, M. Somville, M. Sensi, and T. Boon. 1994. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*16018. Eur. J. Immunol. 24:2134-2140.
25. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
26. Van der Bruggen, P., J. Bastin, T. Gajewski, P.G. Coulie, P. Boel, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24: 3038-3043.
27. Wang, R.-F., P.F. Robbins, Y. Kawakami, X.-Q. Kang, and S.A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181: 799-804.
28. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Wash. DC). 269:1281-1284.
29. Lehmann, F., M. Marchand, P. Haimaut, P. Poullart, X. Sastre, H. Ikeda, T. Boon, and P.G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340-347.
30. Degiovanni, G., T. Lahaye, M. Herin, P. Hainaut, and T. Boon. 1988. Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur. J. Immunol. 18:671-676.
31. De Plaen, E., C. Lurquin, A. Van Pel, B. Mariame, J. Szikora, T. Wölfel, C. Sibille, P. Chomez, and T. Boon. 1988. Immunogenic (tum -) variants of mouse tumor P815: cloning of the gene of turn-antigen P19A and identification of the turn-mutation. Proc. Natl. Acad. Sci. USA. 85:2274-2278.
32. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen to tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373-1380.
33. Lill, N.L., M.J. Tevethia, W.G. Hendrickson, and S.S. Tevethia. 1992. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. J. Exp. Med. 176:449-457.
34. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koeppe, W. Rosenberg, D. Boyd, A. Edwards, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Science (Wash. DC). 369:403-407.
35. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fioccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (Lond.). 369:407-410.
36. Wiedenfeld, E.A., M. Fernanden-Vina, J.A. Berzofsky, and D.P. Carbone. 1994. Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA-A*0201 peptide consensus motif. Cancer Res. 54:1175-1177.
37. Couillin, I., F. Connan, B. Culmann-Penciolelli, E. Gomard, J.-G. Guillet, and J. Choppin. 1995. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding. Eur. J. Immunol. 25:728-732.
38. Rivoltini, L. Y. Kawakami, K. Sakaguchi, S. Southwood, A. Sette, P.F. Robbins, F.M. Marincola, M.L. Salgaller, J.R. Yanelli. E. Appella, and S.A. Rosenberg. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154:2257-2265.
39. Wölfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.-H. Meyer zum Büschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24:759-764.
40. Ferrone, S., F.M. Marincola. 1995. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16:487-494.
41. Beersma, M.F.C., M.J.E. Bijlmakers, and H.J. Ploegh. 1993. Human cytomegalovirus downregulates HLA-class I expression by reducing the stability of class I chains. J. Immunol. 151:4455-4461.
42. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J.Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (Lond.). 375:411-415.
43. D'Urso, C.M., Z. Wang. Y. Cao, R. Tatake, R. Zeff, and S. Ferrone. 1991. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in β2m gene expression. J. Clin. Invest. 87:284-292.
44. Marincola, F.M., P. Shamamian, R.B. Alexader, J.R. Gnarra, R.L. Turetskaya, S.A. Nedospasov, T.B. Simonis, J.K. Taubenberger, J.R. Yanelli, A. Mixon et al. 1994. Loss of HLA haplotype and B locus downregulation in melanoma cell lines. J. Immunol. 153:1225-1237.
45. Maeurer, M.J., S.M. Gollin, W.J. Storkus, W. Swaney, J. Karbach, D.M. Martin, C. Castelli, R. Salter, A. Knuth, and M.T. Lotze. 1996. Tumor escape from immune recognition. Loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clinical Cancer Research. 2:641-652.
46. Guilloux, Y., C. Viret, N. Gervois, E. Le Drea, M.-C. Pandolfino, E. Diez, and F. Joterau. 1994. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur. J. Immunol 24:1966-1973.
47. Piali, L., A. Fichtel, H.-J. Terpe, B.A. Imhof, and R.H. Gisler. 1995. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. Exp. Med. 181:811-816.